In vitro, both types of CAR-T cells inhibited tumor cell growth, with m-IL-13Rα2 CAR-T cells releasing higher levels of IFN-γ and IL-6 compared to h-IL-13Rα2 CAR-T cells. This evidence concerns the gene IL13RA2 and neoplasm.